Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
Diabetes, Obesity & Metabolism
|
May 4, 2019
Effect of liraglutide on estimates of lipolysis and lipid oxidation in obese patients with stable coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial
Christian Anholm, Preman Kumarathurai, Amirsalar Samkani, et al.
Diabetology & Metabolic Syndrome
|
June 6, 2019
Liraglutide improves the beta-cell function without increasing insulin secretion during a mixed meal in patients, who exhibit well-controlled type 2 diabetes and coronary artery disease
Christian Anholm, Preman Kumarathurai, Anders Jürs, et al.
Cardiovascular Diabetology
|
January 6, 2024
The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator
Roopameera Thirumathyam, Erik Arne Richter, Gerrit van Hall, et al.
Schizophrenia Research
|
July 11, 2008
Variation in the purinergic P2RX(7) receptor gene and schizophrenia
Thomas Hansen, Klaus D Jakobsen, Mogens Fenger, et al.
BMJ Open
|
August 11, 2022
Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial
Roopameera Thirumathyam, Erik Arne Richter, Jens Peter Goetze, et al.
Pharmacogenetics and Genomics
|
June 15, 2007
Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment
Stine D Ohlendorff, Charlotte L Tofteng, Jens-Erik B Jensen, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
March 18, 2020
The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery
Christoffer Martinussen, Simon Veedfald, Carsten Dirksen, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
October 26, 2020
Effects of carbohydrate restriction on postprandial glucose metabolism, <b>β</b>-cell function, gut hormone secretion, and satiety in patients with Type 2 diabetes
Mads J Skytte, Amirsalar Samkani, Arne Astrup, et al.
Frontiers in Nutrition
|
September 5, 2022
Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial
Mads N Thomsen, Mads J Skytte, Amirsalar Samkani, et al.
The American Journal of Clinical Nutrition
|
December 1, 2024
Replacing dietary carbohydrate with protein and fat improves lipoprotein subclass profile and liver fat in type 2 diabetes independent of body weight: evidence from 2 randomized controlled trials
Mads N Thomsen, Mads J Skytte, Amirsalar Samkani, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
Diabetes, Obesity & Metabolism
|
May 4, 2019
Effect of liraglutide on estimates of lipolysis and lipid oxidation in obese patients with stable coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial
Christian Anholm, Preman Kumarathurai, Amirsalar Samkani, et al.
Diabetology & Metabolic Syndrome
|
June 6, 2019
Liraglutide improves the beta-cell function without increasing insulin secretion during a mixed meal in patients, who exhibit well-controlled type 2 diabetes and coronary artery disease
Christian Anholm, Preman Kumarathurai, Anders Jürs, et al.
Cardiovascular Diabetology
|
January 6, 2024
The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator
Roopameera Thirumathyam, Erik Arne Richter, Gerrit van Hall, et al.
Schizophrenia Research
|
July 11, 2008
Variation in the purinergic P2RX(7) receptor gene and schizophrenia
Thomas Hansen, Klaus D Jakobsen, Mogens Fenger, et al.
BMJ Open
|
August 11, 2022
Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial
Roopameera Thirumathyam, Erik Arne Richter, Jens Peter Goetze, et al.
Pharmacogenetics and Genomics
|
June 15, 2007
Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment
Stine D Ohlendorff, Charlotte L Tofteng, Jens-Erik B Jensen, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
March 18, 2020
The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery
Christoffer Martinussen, Simon Veedfald, Carsten Dirksen, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
October 26, 2020
Effects of carbohydrate restriction on postprandial glucose metabolism, <b>β</b>-cell function, gut hormone secretion, and satiety in patients with Type 2 diabetes
Mads J Skytte, Amirsalar Samkani, Arne Astrup, et al.
Frontiers in Nutrition
|
September 5, 2022
Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial
Mads N Thomsen, Mads J Skytte, Amirsalar Samkani, et al.
The American Journal of Clinical Nutrition
|
December 1, 2024
Replacing dietary carbohydrate with protein and fat improves lipoprotein subclass profile and liver fat in type 2 diabetes independent of body weight: evidence from 2 randomized controlled trials
Mads N Thomsen, Mads J Skytte, Amirsalar Samkani, et al.
Page
of 9